Skip to content
Clinical Trials – home
AustriaBack to Austria

Clinical trials in St. Poelten

95 clinical trials in St. Poelten, Austria across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

St. Poelten at a glance
95
clinical trials
  • Research sites2
Type of trial
Recruitment status
Quick filters

95 trials in St. Poelten

Open in trial search
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Golimumab
  • Sponsor:Janssen Cilag International
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:ZILEBESIRAN
  • Sponsor:Alnylam Pharmaceuticals Inc.
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Colchicine
  • Sponsor:Medical University Of Graz
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Ro7790121
  • Sponsor:F. Hoffmann-La Roche AG
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Bio89-100
  • Sponsor:89bio Inc.
Investigational
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Bhv-7000
  • Sponsor:Biohaven Therapeutics Ltd.
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Selatogrel
  • Sponsor:Viatris Innovation GmbH
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Morf-057
  • Sponsor:Morphic Therapeutic Inc.
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Golimumab
  • Sponsor:Janssen Cilag International
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Azacitidine
  • Sponsor:AbbVie Deutschland GmbH & Co. KG
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Azd5004
  • Sponsor:AstraZeneca AB
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Elafibranor
  • Sponsor:Ipsen Bioscience Inc.

Other cities in Austria

The busiest research cities in the country

All 47 cities in Austria

Clinical research in St. Poelten

What the registry says about research in the country

01 Oncology Research

Innovative trials focusing on breast cancer, multiple myeloma, and lymphoma treatments. Studies include evaluating new therapeutic approaches for hormone-receptor-positive breast cancer and novel combinations for blood cancers.

  • Advanced breast cancer therapies
  • Multiple myeloma treatments
  • Lymphoma interventions

Several trials are exploring targeted therapies and immunotherapy combinations for better patient outcomes.

02 Inflammatory Conditions

Research targeting atopic dermatitis and inflammatory bowel diseases including Crohn's disease and ulcerative colitis. Studies evaluate new treatment options for managing chronic inflammatory conditions.

  • Dermatological treatments
  • Gastrointestinal disorders
  • Systemic therapies

Trials focus on both adolescent and adult populations, investigating long-term safety and efficacy.

03 Cardiovascular Studies

Investigations into preventing stroke and managing cardiac conditions. Research includes novel anticoagulation approaches and treatments for atrial fibrillation.

  • Stroke prevention
  • Cardiac surgery outcomes
  • Blood clot prevention

Studies evaluate both preventive measures and acute treatment strategies.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).